Literature DB >> 21959193

Surgical treatment combined with NSAIDs in fibrodysplasia ossificans progressiva.

Yangki Seok1, Sukki Cho, Eungbae Lee.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare and disabling genetic disorder characterized by congenital malformation of the great toes and by progressive heterotopic ossification. There is no effective treatment. Conservative management is unsuccessful, and operation result in failure because new ectopic bone forms at the operative site. We report a 10-year-old boy with FOP who underwent surgical management combined with non-steroidal anti-inflammatory drugs (NSAIDs).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959193     DOI: 10.5761/atcs.cr.11.01677

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  3 in total

Review 1.  Challenges in the treatment of fibrodysplasia ossificans progressiva.

Authors:  Kardelen Gencer-Atalay; Ekim Can Ozturk; Ilker Yagci; Pinar Ata; Kenan Delil; Zerrin Ozgen; Gulseren Akyuz
Journal:  Rheumatol Int       Date:  2018-10-20       Impact factor: 2.631

2.  Surgical and Radiological Management of Complicated Uterine Leiomyoma Aided by 3D Models in a Patient with Fibrodysplasia Ossificans Progressiva.

Authors:  Michelle Ho; Beau Y Park; Norman G Rosenblum; Mona Al Mukaddam; Frederick S Kaplan; Victor Kucherov; Scott G Hubosky; Gregory Kane; Vishal Desai; Michael R Kramer; Bon S Ku; Eric S Schwenk; Jaime L Baratta; Deepti Harshavardhana; Zvi Grunwald
Journal:  Am J Case Rep       Date:  2021-06-10

Review 3.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.

Authors:  Anthony Tucker-Bartley; Jordan Lemme; Andrea Gomez-Morad; Nehal Shah; Miranda Veliu; Frank Birklein; Claudia Storz; Seward Rutkove; David Kronn; Alison M Boyce; Eduard Kraft; Jaymin Upadhyay
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.